Comparative in vitro activity of a new quinolone, fleroxacin, against respiratory pathogens from patients with cystic fibrosis.

We evaluated fleroxacin, a newer fluoroquinolone, against isolates from sputum from patients with cystic fibrosis. These isolates included rough and mucoid Pseudomonas aeruginosa, Pseudomonas cepacia, Staphylococcus aureus, Haemophilus influenzae, and Escherichia coli. Selected isolates were tested...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Akaniro, J C, Vidaurre, C E, Stutman, H R, Marks, M I
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1990
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC171958/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2127170/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.34.10.1880
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!